Form 4: Stryker Corp Executive Glenn S. Boehnlein Reports Stock Transactions

Glenn S. Boehnlein, VP and Chief Financial Officer of Stryker Corp, reports the vesting and settlement of performance stock units and associated dividend equivalents, along with a disposition of shares to cover tax obligations.

Summary

• On March 21, 2024, Glenn S. Boehnlein, VP and Chief Financial Officer of Stryker Corp, reported transactions involving Stryker common stock.
• These transactions include the vesting of 256 shares representing dividend equivalents related to previously reported performance stock units.
• Boehnlein also disposed of 5,555 shares to satisfy tax withholding obligations at a price of $353.19 per share.
• Following these transactions, Boehnlein directly owns 25,597 shares of Stryker common stock and indirectly owns 1,518 shares through a 401K.

Sentiment

Score: 5

Explanation: The document reflects standard insider trading activity related to stock-based compensation and tax obligations, indicating a neutral sentiment.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their stock transactions. It is typical for executives to receive stock-based compensation and to sell shares to cover tax obligations upon vesting.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies like Stryker, similar to filings made by executives at Medtronic, Johnson & Johnson, and Zimmer Biomet.
• The transactions reported are typical for executives receiving stock-based compensation and managing their tax liabilities, aligning with common practices in the medical device industry.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they represent routine executive compensation and tax management activities.
• The disclosure provides transparency to shareholders regarding insider transactions, which is a standard corporate governance practice.

Key Dates